Sogroya (somapacitan) is a small molecule pharmaceutical. Somapacitan was first approved as Sogroya on 2021-03-31. It has been approved in Europe to treat growth.
Trade Name |
Sogroya |
Common Name |
Somapacitan |
Indication |
growth |
Drug Class |
Growth hormone derivatives |